Simplex Trading’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
BL
GWMR
VCM
LPC
VFT
RSWM
TCBWMS
AWM
Simplex Trading's CUE Position: Q1 2026 in Review
Simplex Trading reduced its Cue Biopharma (CUE) stake by 66% in Q1 2026, selling an estimated $522 and leaving 29 shares worth $201. The position accounts for ﹤0.01% of the portfolio, ranked #8836.
Simplex Trading first reported a position in CUE in Q1 2020 and has held it in 18 quarters since. The position peaked at $130K in Q4 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.
- Simplex Trading held 29 shares of Cue Biopharma worth $201 as of Q1 2026.
- Simplex Trading sold 56 Cue Biopharma shares in Q1 2026, an estimated $522.
- Cue Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8836 holding.
- Simplex Trading first reported a position in Cue Biopharma in Q1 2020 and has held it in 18 quarters since.
- Simplex Trading's Cue Biopharma position peaked at $130K in Q4 2021.
- 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.